379 related articles for article (PubMed ID: 16954334)
1. Role of AMPKalpha2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle.
Jørgensen SB; Treebak JT; Viollet B; Schjerling P; Vaulont S; Wojtaszewski JF; Richter EA
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E331-9. PubMed ID: 16954334
[TBL] [Abstract][Full Text] [Related]
2. Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle.
Jørgensen SB; Wojtaszewski JF; Viollet B; Andreelli F; Birk JB; Hellsten Y; Schjerling P; Vaulont S; Neufer PD; Richter EA; Pilegaard H
FASEB J; 2005 Jul; 19(9):1146-8. PubMed ID: 15878932
[TBL] [Abstract][Full Text] [Related]
3. Lack of AMPKalpha2 enhances pyruvate dehydrogenase activity during exercise.
Klein DK; Pilegaard H; Treebak JT; Jensen TE; Viollet B; Schjerling P; Wojtaszewski JF
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1242-9. PubMed ID: 17711995
[TBL] [Abstract][Full Text] [Related]
4. α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
Nakano M; Hamada T; Hayashi T; Yonemitsu S; Miyamoto L; Toyoda T; Tanaka S; Masuzaki H; Ebihara K; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Otaka A; Fushiki T; Nakao K
Metabolism; 2006 Mar; 55(3):300-8. PubMed ID: 16483872
[TBL] [Abstract][Full Text] [Related]
5. Genetic impairment of AMPKalpha2 signaling does not reduce muscle glucose uptake during treadmill exercise in mice.
Maarbjerg SJ; Jørgensen SB; Rose AJ; Jeppesen J; Jensen TE; Treebak JT; Birk JB; Schjerling P; Wojtaszewski JF; Richter EA
Am J Physiol Endocrinol Metab; 2009 Oct; 297(4):E924-34. PubMed ID: 19654283
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations.
Halseth AE; Ensor NJ; White TA; Ross SA; Gulve EA
Biochem Biophys Res Commun; 2002 Jun; 294(4):798-805. PubMed ID: 12061777
[TBL] [Abstract][Full Text] [Related]
7. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes.
Sakoda H; Ogihara T; Anai M; Fujishiro M; Ono H; Onishi Y; Katagiri H; Abe M; Fukushima Y; Shojima N; Inukai K; Kikuchi M; Oka Y; Asano T
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1239-44. PubMed ID: 12006353
[TBL] [Abstract][Full Text] [Related]
8. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
Sakamoto K; Göransson O; Hardie DG; Alessi DR
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
[TBL] [Abstract][Full Text] [Related]
9. Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice.
Goirand F; Solar M; Athea Y; Viollet B; Mateo P; Fortin D; Leclerc J; Hoerter J; Ventura-Clapier R; Garnier A
J Physiol; 2007 Jun; 581(Pt 3):1163-71. PubMed ID: 17446219
[TBL] [Abstract][Full Text] [Related]
10. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
11. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.
Jørgensen SB; Viollet B; Andreelli F; Frøsig C; Birk JB; Schjerling P; Vaulont S; Richter EA; Wojtaszewski JF
J Biol Chem; 2004 Jan; 279(2):1070-9. PubMed ID: 14573616
[TBL] [Abstract][Full Text] [Related]
12. Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase gamma3-subunit differentially regulates glycogen accumulation.
Yu H; Hirshman MF; Fujii N; Pomerleau JM; Peter LE; Goodyear LJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E557-65. PubMed ID: 16638825
[TBL] [Abstract][Full Text] [Related]
13. MEF2A binding to the Glut4 promoter occurs via an AMPKα2-dependent mechanism.
Gong H; Xie J; Zhang N; Yao L; Zhang Y
Med Sci Sports Exerc; 2011 Aug; 43(8):1441-50. PubMed ID: 21233771
[TBL] [Abstract][Full Text] [Related]
14. Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle.
Kramer HF; Witczak CA; Fujii N; Jessen N; Taylor EB; Arnolds DE; Sakamoto K; Hirshman MF; Goodyear LJ
Diabetes; 2006 Jul; 55(7):2067-76. PubMed ID: 16804077
[TBL] [Abstract][Full Text] [Related]
15. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle.
Li J; Hu X; Selvakumar P; Russell RR; Cushman SW; Holman GD; Young LH
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E834-41. PubMed ID: 15265762
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift.
Röckl KS; Hirshman MF; Brandauer J; Fujii N; Witters LA; Goodyear LJ
Diabetes; 2007 Aug; 56(8):2062-9. PubMed ID: 17513699
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle and heart LKB1 deficiency causes decreased voluntary running and reduced muscle mitochondrial marker enzyme expression in mice.
Thomson DM; Porter BB; Tall JH; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E196-202. PubMed ID: 16926377
[TBL] [Abstract][Full Text] [Related]
18. AMP kinase is not required for the GLUT4 response to exercise and denervation in skeletal muscle.
Holmes BF; Lang DB; Birnbaum MJ; Mu J; Dohm GL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E739-43. PubMed ID: 15165992
[TBL] [Abstract][Full Text] [Related]
19. PGC-1{alpha} is required for AICAR-induced expression of GLUT4 and mitochondrial proteins in mouse skeletal muscle.
Leick L; Fentz J; Biensø RS; Knudsen JG; Jeppesen J; Kiens B; Wojtaszewski JF; Pilegaard H
Am J Physiol Endocrinol Metab; 2010 Sep; 299(3):E456-65. PubMed ID: 20628026
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic AICAR administration on the metabolic and contractile phenotypes of rat slow- and fast-twitch skeletal muscles.
Bamford JA; Lopaschuk GD; MacLean IM; Reinhart ML; Dixon WT; Putman CT
Can J Physiol Pharmacol; 2003 Nov; 81(11):1072-82. PubMed ID: 14719043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
